Overview

Comparison Study of PF530 and Betaferon in Healthy Subjects

Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety, tolerability, and blood levels of two interferon beta-1b products, Betaferon and PF530, in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Pfenex, Inc
Treatments:
Interferon beta-1b
Interferon-beta
Interferons